Steven D. Ertel, EVP & Chief Operating Officer at ACCELERON PHARMA INC (XLRN), sold 32,270 shares at $34.77 ($1.1M) on 2016-07-01, disclosed to the SEC on 2016-07-06.
Open-market sale of $1.1M XLRN by EVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.77 | 28,304 | $984K | 88.2% |
| 2 | $32.89 | 3,466 | $114K | 10.2% |
| 3 | $34.13 | 500 | $17K | 1.5% |
| Total | $34.56 avg | 32,270 | $1.1M | 100% |
| Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |
| XLRN | SELL | 2015-07-17 | $63K | — | Filing → |